5 Patents
- US124102432025Methods of Treating HIV-1 Infection Utilizing Broadly Neutralizing Human Immunodeficiency Virus Type 1 (HIV-1) Gp120-specific Monoclonal Antibodies
Theraclone Sciences Inc.
0 cites - US123123962025Monoclonal Antibodies Directed Against Trimeric Forms of the HIV-1 Envelope Glycoprotein with Broad and Potent Neutralizing Activity
The Scripps Research Institute.
0 cites - US120180672024Monoclonal Antibodies Directed Against Trimeric Forms of the HIV-1 Envelope Glycoprotein with Broad and Potent Neutralizing Activity
Theraclone Sciences, Inc.
0 cites - US118457892023Methods of Treating HIV-1 Infection Utilizing Broadly Neutralizing Human Immunodeficiency Virus Type 1 (HIV-1) Gp120-specific Monoclonal Antibodies
INTERNATIONAL AIDS VACCINE INITIATIVE, Inc.
0 cites - US115847892023Monoclonal Antibodies Directed Against Trimeric Forms of the HIV-1 Envelope Glycoprotein with Broad and Potent Neutralizing Activity
THERACLONE SCIENCES, Inc.
0 cites